d l sulforaphane sfn (Valiant Co Ltd)
Structured Review

D L Sulforaphane Sfn, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/02193781-cf/DL-Sulforaphane/pmc04837897-160-0-5
Average 90 stars, based on 6 article reviews
Images
1) Product Images from "Beyond antioxidant genes in the ancient NRF2 regulatory network"
Article Title: Beyond antioxidant genes in the ancient NRF2 regulatory network
Journal: Free radical biology & medicine
doi: 10.1016/j.freeradbiomed.2015.06.044
Figure Legend Snippet: (A) Percent of NRF2 target genes overlapping human orthologs of Drosophila Class I, II, or III genes. Orthologs were identified using either the top scoring ortholog only (best ortholog), or all orthologs scoring >2 as described in the text. *P<0.0005, **P<0.001, #P<0.05, based on hypergeometric test. (B) Gene Set Enrichment Analysis (GSEA) comparing conserved human NRF2 target genes (human orthologs of Drosophila Class I genes) and gene expression changes after treatment of LCL cells with sulforaphane (SFN).
Techniques Used: Expressing
Figure Legend Snippet: (A) Human NRF2 ChIP-seq signal from LCL cells treated with DMSO or sulforaphane (SFN) as indicated. Select ancient NRF2 target genes with highly significant binding are represented (ChIP y-axis scale = 0-5000). (B) ChIP-seq signal as in (A) at select ancient NRF2 target genes with moderate binding (ChIP y-axis scale = 0-500). (C) Heatmap representing the response to sulforaphane (SFN), tert-butylhydroquinone (tBHQ), overexpression of NRF2, or overexpression of a dominant negative version of NRF2 (NRF2DN) for reporter constructs driven by the enhancer regions highlighted in panels (A) and (B). NQO1 is a positive control for human NRF2, but is not a conserved target because insects do not have an orthologous gene; the remaining nine are enhancers at deeply conserved NRF2 target genes.
Techniques Used: ChIP-sequencing, Binding Assay, Over Expression, Dominant Negative Mutation, Construct, Positive Control
Related Articles
Incubation:Article Title: Variation of glucoraphanin metabolism in vivo and ex vivo by human gut bacteria Article Snippet: Samples were incubated either with or without 50 μM glucoraphanin (C 2 Bioengineering, Hovedgaden, Denmark) anaerobically in duplicate using a GasPak 150 System (Becton, Dickinson and Company, Franklin Lakes, NJ) for 24 or 48 h at 37°C. .. Briefly, 100 μl urine sample was incubated with 500 μl 100 mM K 2 HPO 4 (pH 8.5) and 600 μl benzene dithiol (1.42 g/l in 2-propanol, Sigma-Aldrich) in a shaking water bath at 65°C for 1 h. A set of Article Title: Variation of glucoraphanin metabolismin vivoandex vivoby human gut bacteria Article Snippet: .. Briefly, 100ml of the urine sample were incubated with 500ml of 100 mM-K2HPO4 (pH 8·5) and 600ml benzenedithiol (1·42 g/l in 2-propanol; Sigma-Aldrich) in a shaking water-bath at 658C for 1 h. A set of |

![(A) Structures of the ARE inducers used in panel B, shown as conjugates to Keap1 C151. The regioselectivity of the thiol addition at the endocyclic β-position of 15d-PGJ2 within the cyclopentenone ring has been established and is reviewed elsewhere [48]. Both Michael acceptor positions within CDDO-Im have been shown to contribute to ARE activation [61]. Only one conjugation is shown for simplicity, and the other Michael acceptor site is marked with an asterisk. (B) MDA-MB-231 cells were transfected with expression vectors for Nrf2, either wild-type Keap1 or Keap1 C151S, and a plasmid containing an ARE-dependent firefly luciferase reporter gene. A plasmid containing a constitutively expressed Renilla luciferase was included to normalize for plasmid levels. The transfected cells were exposed to either DMSO (vehicle), 5 μM <t>sulforaphane,</t> 50 nM CDDO-Im or 25 μM 15d-PGJ2 for 16 h prior to analysis of firefly and Renilla luciferase activities in cell lysates. The y-axis is the ratio of the firefly to Renilla values, and all data are normalized to wt Keap1 with DMSO.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_5926/pmc03865926/pmc03865926__nihms486707f1.jpg)